The

Fleet Dispatch

Daily Briefing ✦ Est. 2026
Health · rolling 7 days37 stories

Health

YESTERDAY

Saturday, November 21, 2026

3 stories

Opinion: When should medical school start?

1 outlet

Our summary

In a letter responding to a First Opinion essay by Rachel E. Fabi and Amy Caruso Brown proposing that medical school start after students take the Step 1 exam, the letter writer says the proposal hinges on the premise that learning foundational sciences and learning to become a physician can be separated without compromising either. The writer says their first year of medical school was peppered with clinical exposure and taught otherwise, describing floundering with a blood pressure cuff during a wellness visit and fumbling for words while interviewing a man waiting for a heart transplant.

Why it matters: Debate over medical school timing weighs clinical exposure against foundational science.

Reporters Talk Measles, Pediatric Care, and Democrats’ Post-Election Healthcare Agenda

Our summary

KFF Health News editor-at-large for public health Céline Gounder discussed the resurgence of measles on NPR's Morning Edition on Nov. 17. Montana correspondent Katheryn Houghton talked about closures of pediatric intensive care units on Montana Public Radio on Nov. 16. Georgia correspondent Briah Lumpkins joined WUGA's The Georgia Health Report on Nov. 13 to discuss Democrats' possible agenda after campaigning on healthcare issues, and Michigan correspondent Kate Wells discussed Democrat Abdul El-Sayed's election to the U.S. Senate and his signature 'Medicare for All' issue on Michigan Public's Stateside on Nov. 10.

Why it matters: Local and national coverage tracks measles, pediatric care capacity, and post-election health agendas.

Opinion: How Kennedy and MAHA could help stop measles

1 outlet

Our summary

This opinion piece notes that after the U.S. lost its measles elimination status, Health Secretary Robert F. Kennedy Jr. posted on X that he wanted to stop measles spread, protect families, and regain elimination status, and said he continues to recommend MMR vaccination as the most effective prevention. The author proposes mobilizing MAHA, a movement Kennedy helped build that has organized millions of Americans around health issues. The piece describes the current discourse as medical societies expressing alarm over the lost status while many politicians blame Kennedy and the Trump administration for an inadequate response, with Kennedy's defenders pushing back.

Why it matters: The U.S. losing elimination status raises questions about how health messaging reaches vaccine-skeptical audiences.

Friday, November 20, 2026

7 stories

Finding an ACA Plan Have You Feeling Overwhelmed? Free Help Is Available

Our summary

First-time shoppers choosing an ACA health plan can find the process confusing due to jargon, costs and the need to estimate income and health needs. HealthQ host Blake Farmer appeared on WAMU's Health Hub on Nov. 18 to share tips for navigating the Obamacare marketplace, and free help is available.

Why it matters: Free guidance can help first-time buyers navigate complex plan choices.

Big Win Sets Up Democrats To Intensify Probe of Trump’s Obamacare Purge

Our summary

A week before the midterm elections, a dozen Democratic senators sent critical letters to 10 health insurance company CEOs asking why the insurers cooperated with what they called a "potentially unlawful" Trump administration effort that led to the rapid cancellation of coverage for 760,000 Affordable Care Act enrollees in late August. After the Democrats' electoral sweep, they will control both the House and Senate in January, lending new weight to the insurance investigation led by Oregon Sen. Ron Wyden, expected to chair the Finance Committee, and independent Sen. Bernie Sanders of Vermont, expected to chair the Health, Education, Labor and Pensions Committee. The article quotes a statement that some insurers might view the inquiry as more high-stakes now that Democrats will have subpoena power.

Why it matters: Democratic control gives the insurance inquiry subpoena power and greater leverage.

Patients have little say in how brain implant trials are done. Ian Burkhart wants to change that

1 outlet

Our summary

A new report from the BCI Pioneers Coalition examines how trials of implanted brain-computer interfaces can better address participants' interests and concerns, including post-trial care, informed consent and neural data privacy, and outlines 13 recommendations for startups, researchers and regulators. Co-founder Ian Burkhart said studies can last years and become a big part of someone's life, and that participants should have as much agency as possible.

Why it matters: Participant-focused standards could shape how neural devices are tested and regulated.

Thursday, November 19, 2026

7 stories

Merck, Isomorphic Labs partner to develop oncology drug candidates

1 outlet

Our summary

Merck and Isomorphic Labs announced a research collaboration to discover small molecule drug candidates against an undisclosed oncology target described as strategically important. The partnership combines Isomorphic's drug design engine with Merck's existing wet lab data, and Merck will handle preclinical and clinical development, manufacturing, and commercialization of any products. George Addona of Merck said the target is of high interest to the company and that pairing its datasets with Isomorphic's technology could be powerful.

Why it matters: Adds another AI-drug-discovery deal between a major pharma and Isomorphic.

STAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatment

1 outlet

Our summary

Erasca says it found a more potent, better-tolerated pan-RAS inhibitor in China than Revolution Medicines' Rasonque, a claim supported so far by limited early-stage data released through press releases. Erasca's market value of $5 billion is a fraction of Revolution Medicines' $35 billion, a gap the newsletter says reflects Revolution's lead but also fuels speculation Erasca could be a takeover target. Erasca is presenting more data on ERAS-0015 on Friday at the EORTC-NCI-AACR meeting in Barcelona.

Why it matters: New data could test Erasca's claims and its takeover appeal.

Listen to the Latest ‘KFF Health News Minute’

Our summary

The KFF Health News Minute is available every Thursday through direct download or an RSS feed. Recent editions featured reports on support for Medicare for All, celebrity full-body scans, hospital financial aid, nursing home alternatives, and immigrants losing eligibility for government health insurance.

Why it matters: Short weekly updates help listeners track health-cost and access developments.

Wednesday, November 18, 2026

2 stories

Meet the Teen Who Called a Hospital Home

Our summary

A 14-year-old named Jaloni was hospitalized at SSM Health Cardinal Glennon Children's Hospital in St. Louis after being shot multiple times. He described severe pain and said strong pain medication made him feel as though he were flying. He said he had been a risk-taking youth among friends who stole without getting caught, and in the hospital relied on his grandmother's reassurance that life would improve after release.

Why it matters: Illustrates the toll of gun violence on a teenage victim's recovery.

Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

Our summary

The Trump administration approved requests from Utah and Maine to expand Medicaid coverage to Native American traditional healing practices, Health and Human Services Secretary Robert F. Kennedy Jr. announced in September. The approvals were granted through waivers, bringing to six the number of states with such Medicaid waivers, alongside Arizona, California, New Mexico, and Oregon. The administration is simultaneously preparing to enforce rules expected to drop millions of people from the program, and California's sweeping Medicaid waiver funding its traditional healing program is set to expire at the end of December.

Why it matters: Expands coverage options for traditional healing while broader Medicaid cuts loom.

Tuesday, November 17, 2026

8 stories

STAT+: With $173 million, new startup takes aim at sickle cell

1 outlet

Our summary

Biotech entrepreneur Romesh Subramanian announced Tuesday the founding of startup Marrow Therapeutics, which raised $173 million in Series A and B funding from Scion Life Sciences, venBio, OrbiMed and others. The company aims to develop a sickle cell treatment intended to match gene therapy's effectiveness without its drawbacks. Subramanian said the treatment is expected to be as good as gene therapy in patients, but that this remains to be proven.

Why it matters: A large funding round backs a bid to rival gene therapy for sickle cell.

STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial

1 outlet

Our summary

Sellas Life Sciences said Tuesday that its experimental immunotherapy galinpepimut-S reduced the risk of death by 41% compared with standard treatment in patients with an advanced stage of acute myeloid leukemia. According to the company, the result met the main goal of a Phase 3 clinical trial. Columnist Adam Feuerstein wrote that he had been wrong about the therapy.

Why it matters: A Phase 3 win could offer a new option for advanced AML.

Moving to a New State? Your Healthcare Might Get More Complicated

Our summary

Jael Samano's move from Illinois to Wisconsin after college brought a new job and her first time living on her own, but she realized before moving that it would also change her healthcare: she would need new providers and would have to learn a new insurance system through her employer. She said finding mental and physical health providers has turned out to be more important than she initially thought. Moving to a new state can change insurance options and even the kind of healthcare a person can access.

Why it matters: Relocating can disrupt coverage and access to providers.

Monday, November 16, 2026

10 stories

STAT+: Venture capitalist John Doerr says AI company, named for his late brother, could help fix primary care

1 outlet

Our summary

Venture capitalist John Doerr became emotional when discussing Tom, a new company being announced and named for his late brother. Tom Health is being spun out of Lumeris, a value-based care firm the Doerr brothers helped found 15 years ago, largely based on ideas from Tom, a physician. Lumeris has raised more than $620 million and employs 1,200 people, according to Pitchbook. Doerr said the company decided on its own to name its AI after Tom, who he said wanted health care to be more personal and wanted doctors to have more time to be doctors.

Why it matters: A prominent investor is backing an AI venture aimed at primary care.

These Governors-Elect Campaigned on Expanding Medicaid. It Won’t Be Easy.

Our summary

In her election-night victory speech, Democrat Keisha Lance Bottoms, Georgia's next governor, cited her campaign promise to expand Medicaid to more low-income adults. A national Democratic landslide giving the party control of Congress will also bring Bottoms and other Democratic gubernatorial candidates into office in several states that have long resisted fully expanding Medicaid under the Affordable Care Act. Governors-elect Cindy Holscher in Kansas, Gina Hinojosa in Texas and David Crowley in Wisconsin also campaigned on broadening access to the joint federal-state program for low-income people or those with disabilities. More than a million people collectively in Georgia and other states would be affected.

Why it matters: New governors' Medicaid pledges face implementation challenges despite party gains.